Safety assessment of allylalkoxybenzene derivatives used as flavouring substances - Methyl eugenol and estragole

Food and Chemical Toxicology

Volumn 40, Issue 7, 2002, Pages 851-870

  Smith, R L ^a   Adams, T B ^b   Doull, J ^c   Feron, V J ^d   Goodman, J I ^e   Marnett, L J ^f   Portoghese, P S ^g   Waddell, W J ^h   Wagner, B M ^i,j   Rogers, A E ^k   Caldwell, J ^a   Sipes, I G ^l  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b Federal Emergency Management Agency   (United States)

^c UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^d TNO   (Netherlands)

^e MICHIGAN STATE UNIVERSITY   (United States)

^f VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF MINNESOTA   (United States)

^h University of Louisville School of Medicine   (United States)

ⁱ NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j Bernard M Wagner Associates   (United States)

^k BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^l UNIVERSITY OF ARIZONA   (United States)

more..

Author keywords

Allylalkoxybenzenes; Carcinogenicity; Dose related; Estragole; Generally recognised as safe (GRAS); Hepatotoxicity; Methyl eugenol; National Toxicology Program

Indexed keywords

BENZENE DERIVATIVE; ESSENTIAL OIL; ESTRAGOLE; EUGENOL; FLAVORING AGENT;

ABSORPTION; BIOCHEMISTRY; BIOTRANSFORMATION; BODY WEIGHT; CANCER RISK; CHRONICITY; CONJUGATE; COVALENT BOND; DATA ANALYSIS; DIET; DOSE RESPONSE; EATING; ENZYME INDUCTION; EXCRETION; EXPERT SYSTEM; EXPOSURE; FOOD ANALYSIS; FOOD INTAKE; GENOTOXICITY; HAZARD ASSESSMENT; LIVER TOXICITY; MAMMAL; METABOLIC ACTIVATION; METABOLISM; METABOLITE; NONHUMAN; REVIEW; RISK ASSESSMENT; RODENT; SPICE; STRUCTURE ANALYSIS; SYNTHESIS; TOXICITY TESTING;

ANIMALS; BIOTRANSFORMATION; EUGENOL; FEMALE; FLAVORING AGENTS; HUMANS;

ANIMALIA; MAMMALIA; RODENTIA;

EID: 0036286160     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0278-6915(02)00012-1     Document Type: Review

References (75)

1. Metabolism of estragole in rat and mouse and influence of dose size on excretion of the proximate carcinogen 1′-hydroxyestragole
2. Levels of methyleugenol in a subset of adults in the general US population as determined by high resolution mass spectrometry
3. Absorption, metabolism and excretion of safrole in the rat and man
4. Strong evidence from studies with brachymorphic mice and pentachlorophenol that 1′-sulfooxysafrole is the major ultimate electrophilic and carcinogenic metabolite of 1′-hydroxysafrole in mouse liver
5. Etude de L'Arome Basilic
6. Metabolism of the naturally occurring hepatocarcinogen safrole to l-hydroxysafrole and the electrophilic reactivity of l-acetoxysafrole
7. Saturated and monofluoro analogs of the oriental fruit fly attractant methyl eugenol show reduced genotoxic activities in yeast
8. The in vivo disposition and metabolism of methyleugenol in the Fischer 344 rat and the B6C3F1 mouse
9. 14C]anethole in human volunteers
10. 1′-Hydroxylation is the only metabolic pathway of simple alkenylbenzenes involved in their genotoxicity
11. Comparative induction of unscheduled DNA. synthesis in cultured rat hepatocytes by allylbenzenes and their 1′-hydroxy metabolites
12. Biotransformation of allylbenzene analogues in vivo and in vitro through the epoxide-diol pathway
13. Mutagenicity of the metabolites of the epoxide diol pathway of safrole and analogs. Study on Salmonella typhimurium
14. Hepatocarcinogenicity of estragole (1-allyl-4-methoxybenzene) and 1′-hydroxyestragole in the mouse and mutagenicity of 1′-acetoestragole in bacteria
15. Protein adducts derived from methyleugenol
16. Immunochemical detection of covalently modified protein adducts in livers of rats treated with methyleugenol
17. Covalent modification of the laminin receptor precursor protein by reactive metabolites of methyleugenol
18. Determination of methyleugenol in rodent plasma by high-performance liquid chromatography. Journal of Chromatography B:
19. Jamaican and Central American Pimento (Allspice; Pimenta dioica): Characterization of flavour differences and other distinguishing features
20. Food flavorings and compounds of related structure. II. Subacute and chronic toxicity
21. Recent progress in the consideration of flavoring ingredients under the food additives amendment III. GRAS substances
22. Structure-specificity of the genotoxicity of some naturally occurring alkenylbenzenes determined by the unscheduled DNA synthesis assay in rat hepatocytes
23. Importance of demethylenation in the metabolism in vivo and in vitro of methylenedioxyphenyl synergists and related compounds in mammals
24. 6 is dependent on both the chirality of the lesion and local sequence context
25. Is the development of an essential oil industry in Malaysia a viable commercial opportunity?
26. A further examination of the variation of Ocimum basilicum L
27. Essential oils as components of mixtures: Their method of analysis and differentiation
28. Esophageal tumours produced in rats by the feeding of dihydrosafrole
29. Metabolism of allylbenzene 2′,3′-oxide and estragole 2′,3′-oxide in the isolated perfused rat liver
30. Covalent binding to DNA in vitro of 2′,3′-oxides derived from allylbenzene analogs
31. Methyleugenol in Ocimum basilicum L. Cv, Genovese Gigante
32. The metabolic activation and carcinogenicity of alkenylbenzenes that occur naturally in many spices
33. Structure-activity studies of the carcinogenicities in the mouse and rat of some naturally occurring and synthetic alkenylbenzene derivatives related to safrole and estragole
34. Salmonella mutagenicity tests: II. Results from the testing of 270 chemicals
35. The genotoxic potential in vitro and in vivo of the allyl benzene etheric oils estragole, basil oil and trans-anethole
36. The FEMA GRAS assessment of trans-anethole used as a flavouring substance
37. Structures of the DNA adducts formed in mouse liver after administration of the proximate hepatocarcinogen 1′-hydroxyestragole
38. 32P-Post-labelling analysis of DNA adducts formed in the livers of animals treated with safrole, estragole and other naturally occurring alkenylbenzenes. II. Newborn male B6C3F1 mice
39. Neuroendocrine cell hyperplasia and neuroendocrine carcinoma of the rodent fundic stomach
40. 32P-Post-labelling analysis of DNA adducts formed in the livers of animals treated with safrole, estragole and other naturally-occurring alkenylbenzenes. I. Adult female CD-1 mice
41. Inhibition of rat, mouse and human glutathione S-transferase by eugenol and its oxidation products
42. The dose dependent metabolism of anethole, estragole and p-propylanisole in relation to their safety evaluation
43. 14C)-labeled trans-anethole, estragole and p-propylanisole in human volunteers
44. Safrole, eugenol and methyleugenol induce intrachromosomal recombination in yeast
45. Genotoxicity of safrole-related chemicals in microbial test systems
46. Effects of dietary curcumin on glutathione S-transferase and malondialdehyde-DNA adducts in rat liver and colon mucosa: Relationship with drug levels
47. Flavor characteristic compounds found in the essential oil of Ocimum basilicum L. with sensory evaluation and statistical analysis
48. Metabolism of alkenebenzene derivatives in the rat. II. Eugenol and isoeugenol methyl ethers
49. Consumption ratio and food predominance of flavoring material
50. Dose-dependent variation in the disposition of eugenol in rat
51. The mutagenicities of safrole, estrogole eugenol, trans-anethole, and some of their known or possible metabolites for Salmonella typhimurium mutants
52. The side-chain epoxidation and hydroxylation of the hepatocarcinogens safrole and estragole and some related compounds by rat and mouse liver microsomes
53. A study of the mechanism of butachlor-associated gastric neoplasms in Sprague-Dawley rats
54. Mutagenicity of trans-anethole, estragole, eugenol and safrole in the Ames Salmonella typhimurium assay
55. Essential oil of Ocimum basilicum L. cultivated in Taiwan
56. Further characterization of the DNA adducts formed by electrophilic esters of the hepatocarcinogens 1′-hydroxysafrole and 1′-hydroxyestragole in vitro and in mouse liver in vivo, including new adducts at C-8 and N-7 of guanine residues
57. Structure-activity studies of the hepatocarcinogenicities of alkenylbenzene derivatives related to estragole and safrole on administration to preweanling male C57BL/6J×C3H/HeJ F1 mice
58. Effects of gavage versus dosed feed administration on the toxicokinetics of benzyl acetate in rats and mice
59. Dose dependent conversion of estragole in the rat and mouse to the carcinogenic metabolite, 1′-hydroxyestragole
60. Studies on the genotoxic properties of essential oils with Bacillus subtilis rec-assay and Salmonella microsome reversion assay
61. Salmonella mutagenicity tests: III. Results from testing 255 chemicals